Announcement on Convening the 2025 Semi-annual Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Convening the 2025 Semi-annual Performance Briefing
Filed with SSE ·
6ix hasn’t read this filing yet.
Shanghai ZJ Bio-Tech Co. Ltd on 6ix
Earlier from Shanghai ZJ Bio-Tech
- Announcement on Voluntary Disclosure of Company Products Being Included in the WHO Emergency Use Listing
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 13th Meeting of the 5th Board of Supervisors
- Announcement on Implementation Results of the 2nd Share Repurchase in 2025
- Announcement on Progress in Repurchasing Shares through Call Auction for the Second Time in 2025
Later from Shanghai ZJ Bio-Tech
- Announcement on the 3rd Plan in 2025 for Repurchasing Shares through Call Auction
- Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Without Sales Restrictions Concerning Share Repurchase
- Announcement on Reversal of Asset Impairment Provision for the First Three Quarters of 2025
- Sanyou Bio and Shanghai ZJ Bio-Tech Sign Strategic Cooperation Agreement on Automated Development of Innovative Biologics to Jointly Tackle R&D Bottlenecks and Provide New Momentum for Innovative Drug R&D
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
Follow Shanghai ZJ Bio-Tech into a list and get an email when it puts out news.
Follow Shanghai ZJ Bio-Tech